BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wijtmans M, Celanire S, Snip E, Gillard MR, Gelens E, Collart PP, Venhuis BJ, Christophe B, Hulscher S, van der Goot H, Lebon F, Timmerman H, Bakker RA, Lallemand BI, Leurs R, Talaga PE, de Esch IJ. 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists. J Med Chem 2008;51:2944-53. [PMID: 18433114 DOI: 10.1021/jm7014149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Ishikawa M, Shinei R, Yokoyama F, Yamauchi M, Oyama M, Okuma K, Nagayama T, Kato K, Kakui N, Sato Y. Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice. J Med Chem 2010;53:3840-4. [DOI: 10.1021/jm901890s] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
2 Bolje A, Urankar D, Košmrlj J. Synthesis and NMR Analysis of 1,4-Disubstituted 1,2,3-Triazoles Tethered to Pyridine, Pyrimidine, and Pyrazine Rings: 1,2,3-Triazoles Tethered to Heterocycles. Eur J Org Chem 2014;2014:8167-81. [DOI: 10.1002/ejoc.201403100] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
3 Ishikawa M, Watanabe T, Kudo T, Yokoyama F, Yamauchi M, Kato K, Kakui N, Sato Y. Investigation of the Histamine H3 Receptor Binding Site. Design and Synthesis of Hybrid Agonists with a Lipophilic Side Chain. J Med Chem 2010;53:6445-56. [DOI: 10.1021/jm100643t] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
4 Ishikawa M, Furuuchi T, Yamauchi M, Yokoyama F, Kakui N, Sato Y. Synthesis and structure–activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorganic & Medicinal Chemistry 2010;18:5441-8. [DOI: 10.1016/j.bmc.2010.04.052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
5 Peng YH, Ueng SH, Tseng CT, Hung MS, Song JS, Wu JS, Liao FY, Fan YS, Wu MH, Hsiao WC, Hsueh CC, Lin SY, Cheng CY, Tu CH, Lee LC, Cheng MF, Shia KS, Shih C, Wu SY. Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1. J Med Chem 2016;59:282-93. [PMID: 26642377 DOI: 10.1021/acs.jmedchem.5b01390] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 14.4] [Reference Citation Analysis]
6 Wágner G, Mocking TAM, Arimont M, Provensi G, Rani B, Silva-Marques B, Latacz G, Da Costa Pereira D, Karatzidou C, Vischer HF, Wijtmans M, Kieć-Kononowicz K, de Esch IJP, Leurs R. 4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H3 Receptor Agonists with in Vivo Central Nervous System Activity. J Med Chem 2019;62:10848-66. [PMID: 31675226 DOI: 10.1021/acs.jmedchem.9b01462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Nakagawa S, Bainbridge KA, Butcher K, Ellis D, Klute W, Ryckmans T. Application of Barluenga Boronic Coupling (BBC) to the Parallel Synthesis of Drug-like and Drug Fragment-like Molecules. ChemMedChem 2012;7:233-6. [DOI: 10.1002/cmdc.201100339] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
8 Stockmann H, Todorovic V, Richardson PL, Marin V, Scott V, Gerstein C, Lake M, Wang L, Sadhukhan R, Vasudevan A. Cell-Surface Receptor–Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors. J Am Chem Soc 2017;139:16822-9. [DOI: 10.1021/jacs.7b09359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
9 Bellina F, Rossi R. Regioselective Functionalization of the Imidazole Ring via Transition Metal-Catalyzed CN and CC Bond Forming Reactions. Adv Synth Catal 2010;352:1223-76. [DOI: 10.1002/adsc.201000144] [Cited by in Crossref: 117] [Cited by in F6Publishing: 87] [Article Influence: 9.8] [Reference Citation Analysis]
10 Kurhade SE, Ravula S, Siddaiah V, Bhuniya D, Reddy DS. Synthesis of novel dihydrooxazine and oxazoline based sugar hybrids from sugar azides. Tetrahedron Letters 2011;52:4313-5. [DOI: 10.1016/j.tetlet.2011.06.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Célanire S, Wijtmans M, Christophe B, Collart P, de Esch I, Dassesse D, Delaunoy C, Denonne F, Durieu V, Gelens E, Gillard M, Lallemand B, Lamberty Y, Lebon F, Nicolas J, Quéré L, Snip E, Vanbellinghen A, Van houtvin N, Verbois V, Timmerman H, Talaga P, Leurs R, Provins L. Discovery of a New Class of Non-imidazole Oxazoline-Based Histamine H 3 Receptor (H 3 R) Inverse Agonists. ChemMedChem 2009;4:1063-8. [DOI: 10.1002/cmdc.200900055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Hosseini A, Khalilzadeh MA, Hosseinzadeh M, Tajbakhsh M. A simple method for iodination of heterocyclic compounds using HIO4/NaCl/silica gel/H2SO4 in water. Monatsh Chem 2012;143:619-23. [DOI: 10.1007/s00706-011-0611-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
13 Moya-García AA, Pino-Angeles A, Gil-Redondo R, Morreale A, Sánchez-Jiménez F. Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition. Br J Pharmacol 2009;157:4-13. [PMID: 19413567 DOI: 10.1111/j.1476-5381.2009.00219.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
14 Basolo L, Beccalli EM, Borsini E, Broggini G. Efficient palladium-catalyzed direct arylation of azines and diazines using ligand-free conditions. Tetrahedron 2009;65:3486-91. [DOI: 10.1016/j.tet.2009.02.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
15 Hauwert NJ, Mocking TAM, Da Costa Pereira D, Lion K, Huppelschoten Y, Vischer HF, De Esch IJP, Wijtmans M, Leurs R. A Photoswitchable Agonist for the Histamine H3 Receptor, a Prototypic Family A G-Protein-Coupled Receptor. Angew Chem Int Ed Engl 2019;58:4531-5. [PMID: 30735597 DOI: 10.1002/anie.201813110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Levoin N, Labeeuw O, Billot X, Calmels T, Danvy D, Krief S, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening. Eur J Med Chem 2017;125:565-72. [PMID: 27718472 DOI: 10.1016/j.ejmech.2016.09.074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Strasser A. Molecular modeling and QSAR-based design of histamine receptor ligands. Expert Opinion on Drug Discovery 2009;4:1061-75. [DOI: 10.1517/17460440903264972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Bae S, Jang H, Jung H, Joo JM. Catalytic C–H Allylation and Benzylation of Pyrazoles. J Org Chem 2015;80:690-7. [DOI: 10.1021/jo5025317] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]